2017 Interviews

Data Management in Process Development as a Key to Process Understanding and Development Efficiency

Martin Mayer, Ph.D., Director, evon GmbH, Austria

Cambridge Healthtech Institute’s Kent Simmons recently spoke with Dr. Martin Mayer, a Director with Austria’s evon GmbH, Austria, about his upcoming presentation “Data Management in Process Development as a Key to Process Understanding and Development Efficiency”, to be delivered in the Process Characterization and Control meeting at the 2017 Bioprocessing Summit. The Summit is scheduled for August 21-25 at the Westin Copley Place hotel in Boston, with the process charactertization program set for August 24-25.
View the Interview

Interviews

Epigenetic Effects on Antibody Production in CHO Cells

Susan Sharfstein, Ph.D., Associate Professor, Nanobioscience, Nanoscale Science and Engineering, SUNY Polytechnic Institute

Dr. Susan Sharfstein, Associate Professor of Nanoscale Science and Engineering at SUNY Polytechnic Institute, and a speaker at the upcoming Optimizing Cell Line Development conference shares insight on her presentation "Epigenetic Effects on Antibody Production in CHO Cells".
View the Interview

Optimization, Simplification and Intensification of Cell Culture Processes

Jochen_SieckJochen B. Sieck, Ph.D., Lab Head, Cell Culture Media R&D, Process Solutions R&D, Merck KGaA

Dr. Jochen B. Sieck, Lab Head of Cell Culture Media R&D, Process Solutions R&D, at Merck KGaA shares insight on his presentation "Optimization, Simplification and Intensification of Cell Culture Processes" to be featured at the upcoming Optimizing Cell Culture Technology conference being held in Boston.
View the Interview

Plant-Wide Process Control Model for Biological Manufacturing

Richard D. Braatz is the Edwin R. Gilliland Professor of Chemical Engineering at MIT.

Cambridge Healthtech Institute’s Kent Simmons recently spoke with Richard D. Braatz about his upcoming presentation “Plant-Wide Process Control Model for Biological Manufacturing,” to be held August 19 in Boston as part of the Process Characterization, Qualification and Control conference at the 8th Annual Bioprocessing Summit.
View the Interview | Download the PDF

Harmonizing Transient and Stable CHO Expression Platforms for Early-Phase Drug Discovery

Dr. Yashas Rajendra, Research Scientist of Bio-TDR Cell Culture at Eli Lilly and Company

Dr. Yashas Rajendra, Research Scientist of Bio-TDR Cell Culture at Eli Lilly and Company, and a speaker at the upcoming "Optimizing Cell Culture Technology Conference" shares insight on streamlining the discovery process by minimizing the risk when molecules move forward in the portfolio.
View the Interview | Download the PDF

OutlookYouTubeFacebookLinkedInTwitter #BPSMT

Premier Sponsor

Unchained Labs(1)